|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Reents
PRN | Corporate Officer/Principal | 59 | - |
Dana Lee
PRN | Corporate Officer/Principal | 62 | 2013-01-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.03% | +3.77% | +12.35% | +37.22% | 49.06B | |
| -0.73% | -0.23% | +49.11% | +36.96% | 44.6B | |
| +0.85% | +5.16% | +340.22% | +632.70% | 43.24B | |
| -0.31% | -0.54% | +9.99% | +103.53% | 41.73B | |
| +0.34% | -1.38% | +5.53% | +47.36% | 29.93B | |
| +0.73% | -1.46% | +24.01% | +156.46% | 17.19B | |
| -3.19% | +6.80% | +4.93% | - | 15.35B | |
| -3.20% | -3.50% | +25.33% | +42.43% | 15.54B | |
| -0.65% | -3.76% | - | - | 15.11B | |
| Average | -0.72% | +1.76% | +58.93% | +150.95% | 30.19B | |
| Weighted average by Cap. | -0.41% | +2.17% | +73.92% | +165.44% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
